Asymptomatic lone atrial fibrillation-how can we detect the arrhythmia?

Current Pharmaceutical Design

Volumn 21, Issue 5, 2015, Pages 659-666

  Boriani, Giuseppe ^a   Valzania, Cinzia ^a   Biffi, Mauro ^a   Diemberger, Igor ^a   Ziacchi, Matteo ^a   Martignani, Cristian ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Electrocardiography; Lone atrial fibrillation; Monitoring; Stroke; Thromboembolism

Indexed keywords

AMBULATORY MONITORING; ARTICLE; ASYMPTOMATIC DISEASE; ASYMPTOMATIC LONE ATRIAL FIBRILLATION; BLOOD PRESSURE MONITORING; CAMERA; ELECTROCARDIOGRAPHY MONITORING; HEART ATRIUM FIBRILLATION; HUMAN; IMPLANTABLE CARDIAC MONITOR; INCIDENCE; MASS SCREENING; MOBILE PHONE; OPPORTUNISTIC SCREENING; PALPATION; PREVALENCE; PRIORITY JOURNAL; PULSE RATE; SYSTEMATIC SCREENING; ATRIAL FIBRILLATION; COMPLICATION; ELECTROCARDIOGRAPHY; ELECTRODE IMPLANT; PROCEDURES; STROKE;

ASYMPTOMATIC DISEASES; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY, AMBULATORY; ELECTRODES, IMPLANTED; HUMANS; MASS SCREENING; PALPATION; PULSE; STROKE;

EID: 84925850585     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666140825142639     Document Type: Article

References (73)

1. Boriani G, Diemberger I, Martignani C, Biffi M, Branzi A. The epidemiological burden of atrial fibrillation: a challenge for clinicians and health care systems. Eur Heart J 2006; 27: 893-4.
2. Lip GY, Brechin CM, Lane DA. The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest 2012; 142: 1489-98.
3. Boriani G, Diemberger I. Globalization of the epidemiologic, clinical, and financial burden of atrial fibrillation. Chest 2012; 142: 1368-70.
4. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-25.
5. Stefansdottir H, Aspelund T, Gudnason V, Arnar DO. Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace 2011; 13: 1110-7.
6. Potpara TS, Lip GY. Lone atrial fibrillation: what is known and what is to come. Int J Clin Pract 2011; 65: 446-57.
7. Evans W, Swann P. Lone auricular fibrillation. Br Heart J 1954; 16: 189-94.
8. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-354.
9. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-429.
10. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation. 30 year follow-up in the Framingham study. JAMA 1985; 254: 3449-53.
11. Jahangir A, Lee V, Friedman PA et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study, Circulation 2007; 115: 3050-56.
12. Kopecky SL. Idiopathic atrial fibrillation: prevalence, course, treatment, and prognosis. J Thromb Thrombolysis 1999; 7: 27-31.
13. Weijs B, Pisters R, Nieuwlaat R et al. Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort. Europace 2012; 14: 184-90.
14. Wyse DG. Idiopathic atrial brillation: a rose by any other name? Europace 2012; 14: 151-2.
15. Frost L. Lone atrial fibrillation: good, bad, or ugly? Circulation 2007; 115: 3040-1.
16. Schoonderwoerd BA, Smit MD, Pen L, VanGelder IC. New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation' Europace 2008; 10: 668-73.
17. Boriani G, Cervi E, Diemberger I, et al. Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. Chest 2011; 140: 843-5.
18. Kirchhof P, Breithardt G, Aliot E, et al. Personalized management of atrial fibrillation: proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus Conference. Europace 2013; 15: 1540-56.
19. Boriani G, Diemberger I, Ziacchi M, et al. AF burden is important-fact or fiction? Int J Clin Pract. 2014; 68: 444-52.
20. Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke 2004; 35: 1647-51.
21. Lip GY, Golding DJ, Nazir M, Beevers DG, Child DL, Fletcher RI. A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project. Br J Gen Pract 1997; 47: 285-9.
22. Mittal S, Movsowitz C, Steinberg JS. Ambulatory external electrocardiographic monitoring. Focus on atrial fibrillation. J Am Coll Cardiol 2011; 58: 1741-9.
23. Moran PS, Flattery MJ, Teljeur C, Ryan M, Smith SM. Effectiveness of systematic screening for the detection of atrial fibrillation. Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD009586. DOI: 10.1002/14651858.CD009586.pub2.
24. Morgan S, Mant D. Randomised trial of two approaches to screening for atrial fibrillation in UK general practice. Br J Gen Pract 2002; 52:373-80.
25. Somerville S, Somerville J, Croft P, Lewis M. Atrial fibrillation: a comparison of methods to identify cases in general practice. Br J Gen Pract 2000; 50:727-9.
26. Mant J, Fitzmaurice DA, Hobbs R, et al. Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial. BMJ 2007; 335(7616): 380.
27. Doliwa PS, Frykman V, Rosenqvist M. Short-term ECG for out of hospital detection of silent atrial fibrillation episodes. Scand Cardiovasc J 2009; 43: 163-8.
28. Lewis M, Parker D, Weston C, Bowes M. Screening for atrial fibrillation: sensitivity and specificity of a new methodology. Br J Gen Pract 2011; 61: 38-9.
29. Wiesel J, Wiesel D, Suri R, Messineo FC. The use of a modified sphygmomanometer to detect atrial fibrillation in outpatients. Pacing Clin Electrophysiol 2004; 27: 639-43.
30. Stergiou GS, Karpettas N, Protogerou A, Nasothimiou EG, Kyriakidis M. Diagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation. J Hum Hypertens 2009; 23: 654-8.
31. Wiesel J, Fitzig L, Herschman Y, Messineo FC. Detection of atrial fibrillation using a modified microlife blood pressure monitor. Am J Hypertens 2009; 22: 848-52.
32. McManus DD, Lee J, Maitas O, et al. A novel application for the detection of an irregular pulse using a smartphone (iPhone 4S) in patients with atrial fibrillation. Heart Rhythm 2013; 10: 315-9.
33. Hobbs FDR, Fitzmaurice DA, Jowett S, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technology Assessment 2005; 9: 40.
34. Raviele A, Giada F, Bergfeldt L, et al. Management of patients with palpitations: a position paper from the European Heart Rhythm Association. Europace 2011; 13: 920-34.
35. Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology. J Am Coll Cardiol 1999; 34: 912-48.
36. Rothman SA, Laughlin JC, Seltzer J, et al. The diagnosis of cardiac arrhythmias: a prospective multi-center randomized study comparing mobile cardiac outpatient telemetry versus standard loop event monitoring. J Cardiovasc Electrophysiol 2007; 18: 241-7.
37. Turakhia MP, Hoang DD, Zimetbaum P, et al. Diagnostic utility of a novel leadless arrhythmia monitoring device. Am J Cardiol 2013; 112: 520-4.
38. Rosenberg MA, Samuel M, Thosani A, Zimetbaum PJ. Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin Electrophysiol 2013; 36: 328-33.
39. Liao J, Khalid Z, Scallan C, Morillo C, O’Donnell M. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke 2007; 38: 2935-40.
40. Elijovich L, Josephson SA, Fung GL, Smith WS. Intermittent atrial fibrillation may account for a large proportion of otherwise cryptogenic stroke: a study of 30-day cardiac event monitors. J Stroke Cerebrovasc Dis 2009; 18: 185-9.
41. Flint AC, Banki NM, Ren X, Rao VA, Go AS. Detection of paroxysmal atrial fibrillation by 30-day event monitoring in cryptogenic ischemic stroke: the Stroke and Monitoring for PAF in Real Time (SMART) Registry. Stroke 2012; 43: 2788-90.
42. Miller DJ, Khan MA, Schultz LR, et al. Outpatient cardiac telemetry detects a high rate of atrial fibrillation in cryptogenic stroke. J Neurol Sci 2013; 324: 57-61.
43. Kamel H, Navi BB, Elijovich L, et al. Pilot randomized trial of outpatient cardiac monitoring after cryptogenic stroke. Stroke 2013; 44: 528-30.
44. Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014; 370: 2478-86.
45. Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Europace 2007; 9: 335-79.
46. Zimetbaum P, Goldman A. Ambulatory arrhythmia monitoring: choosing the right device. Circulation 2010; 122: 1629-36.
47. Ziegler PD, Koehler JL, Mehra R. Comparison of continuous versus intermittent monitoring of atrial arrhythmias. Heart Rhythm 2006; 3: 1445-52.
48. Doliwa PS, Rosenqvist M, Frykman V. Paroxysmal atrial fibrillation with silent episodes: intermittent versus continuous monitoring. Scand Cardiovasc J 2012; 46:144-8.
49. Vasamreddy CR, Dalal D, Dong J, et al. Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation. J Cardiovasc Electrophysiol 2006; 17: 134-9.
50. Camm AJ, Corbucci G, Padeletti L. Usefulness of continuous electrocardiographic monitoring for atrial fibrillation. Am J Cardiol 2012; 110: 270-6.
51. Pontoppidan J, Nielsen JC, Poulsen SH, Hansen PS. Symptomatic and asymptomatic atrial fibrillation after pulmonary vein ablation and the impact on quality of life. Pacing Clin Electrophysiol 2009; 32: 717-26.
52. Zimetbaum PJ, Kim KY, Josephson ME, Goldberger AL, Cohen DJ. Diagnostic yield and optimal duration of continuous-loop event monitoring for the diagnosis of palpitations. A cost-effectiveness analysis. Ann Intern Med 1998; 128: 890-5.
53. Kamel H, Hegde M, Johnson DR, Gage BF, Johnston SC. Costeffectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke. Stroke 2010; 41: 1514-20.
54. Botto GL, Padeletti L, Santini M, et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 2009; 20: 241-8.
55. Boriani G, Botto GL, Padeletti L, et al. Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring. Stroke 2011; 42: 1768-70.
56. Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012; 366: 120-9.
57. Boriani G, Santini M, Lunati M, et al. Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: the multicentre Italian ANGELS of AF Project. Circ Cardiovasc Qual Outcomes 2012; 5: 182-8.
58. Glotzer TV, Hellkamp AS, Zimmerman J, et al; MOST Investigators. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 2003; 107: 1614-9.
59. Capucci A, Santini M, Padeletti L, et al; Italian AT500 Registry Investigators. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 2005; 46: 1913-20.
60. Glotzer TV, Daoud EG, Wyse DG, et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol 2009; 2: 474-80.
61. Shanmugam N, Boerdlein A, Proff J, et al. Detection of atrial highrate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population. Europace 2012; 14: 230-7.
62. Boriani G, Glotzer TV, Santini M, et al. Device detected atrial fibrillation and risk for stroke: an analysis of more than 10,000 patients from the SOS AF project (Stroke Prevention Strategies based on Atrial Fibrillation information from implanted devices). Eur Heart J. 2014; 35: 508-16.
63. Boriani G, Da Costa A, Ricci RP, et al. The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) Randomized Controlled trial: phase 1 results on early decision making with remote monitoring. J Med Internet Res 2013; 15(8): e167.
64. Hindricks G, Pokushalov E, Urban L, et al., Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial, Circ Arrhythm Electrophysiol 2010; 3: 141-7.
65. Cotter PE, Martin PJ, Ring L, Warburton EA, Belham M, Pugh PJ. Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke. Neurology 2013; 80: 1546-50.
66. Ritter MA, Kochhäuser S, Duning T, et al. Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors. Stroke 2013; 44: 1449-52.
67. Etgen T, Hochreiter M, Mundel M, Freudenberger T. Insertable cardiac event recorder in detection of atrial fibrillation after cryptogenic stroke: an audit report. Stroke 2013; 44: 2007-9.
68. Pokushalov E, Romanov A, Corbucci G, et al. Does atrial fibrillation burden measured by continuous monitoring during the blanking period predict the response to ablation at 12-month follow-up? Heart Rhythm 2012; 9: 1375-9.
69. Potpara TS, Stankovic GR, Beleslin BD, et al. A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study. Chest. 2012; 141: 339-47.
70. Boriani G, Diemberger I, Biffi M. Atrial fibrillation: it is better to be alone than in bad company! Chest. 2012; 141: 290-2.
71. Boriani G. How do cardiologists face health economics and health technology assessments? Eur Heart J. 2012; 33:2757-8.
72. Maniadakis N, Vardas P, Mantovani LG, Fattore G, Boriani G. Economic evaluation in cardiology. Europace. 2011;13 Suppl 2:ii3-8.
73. Boriani G, Maniadakis N, Auricchio A et al. Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association. Eur Heart J. 2013; 34:1869-74.